VERSES AI Inc. Announces Closing of First Tranche of LIFE Private Placement Offering
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:…
GoldHaven Completes Acquisition of Copper Peak Metals Inc.
VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS0) announces that, further to its news release of…
Exodus to Announce Third Quarter 2024 Results on November 12, 2024
OMAHA, Neb., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (OTCQX: EXOD), (the “Company” or “Exodus”) the leading self-custodial cryptocurrency software platform, will release financial results for the third…
Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit
Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish efficacy of GTX-102 Phase 3 program on track to begin…
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Upcoming Vote of CAC, OB, SMAR and PFC
NEW YORK, Nov. 10, 2024 (GLOBE NEWSWIRE) -- NEW YORK, November 10, 2024 /GlobeNewswire/-- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders…
Clover Leaf Capital Corp. Announces Termination of Merger Agreement, Cancellation of Special Meeting and its Intention to Liquidate
MIAMI, FL, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Clover Leaf Capital Corp. (OTC: CLOE) (the “Company” or “Clover Leaf”), announced today that Clover Leaf and Kustom Entertainment, Inc. (“Kustom Entertainment”)…
DFCU Financial Announces Intent to Acquire Winter Park National Bank, Expanding Florida Footprint
DEARBORN, Mich. and WINTER PARK, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- DFCU Financial, one of Michigan's largest and most trusted credit unions, is pleased to announce its intent to…
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)
Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity across all subgroups with injected and non-injected lesions responding with similar frequency, depth, duration, and kinetics Initial biomarker data shows…
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort of FT825 / ONO-8250 as Monotherapy Shows Favorable Safety Profile…
Fnac Darty and Ruby Successfully Reach 91.1% of the Share Capital of Unieuro, Which Will be Delisted
PRESS RELEASEIvry-sur-Seine, France — November 8, 2024, 19h15 CEST THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT PERMITTED IN…